News

Our compound TLD1433 has entered a human clinical trial! UPDATE: 3 patients treated! Six more to be enrolled in the study.

Our compound TLD1433 is in a clinical trial for non-muscle invasive bladder cancer! The primary and secondary objectives for the first three patients were met, so a further six patients are to be enrolled in the second part of the study. (Updated 2017-05-31)